The role of genetic factors, such as factor V Leiden and G20210A prothrombin mutations in the multifactorial pathogenesis of thrombosis in the setting of IBD has been frequently reviewed and remains controversial. This evidence concerns the gene F5 and inflammatory bowel disease.